<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Edinburgh Research Explorer Antitumor potential of S-nitrosothiol-containing polymeric nanoparticles against melanoma</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Letícia</forename><forename type="middle">S</forename><surname>Ferraz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Natural and Human Sciences (CCNH)</orgName>
								<orgName type="institution">Federal University of ABC (UFABC)</orgName>
								<address>
									<addrLine>Santo André</addrLine>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carolina</forename><forename type="middle">M</forename><surname>Watashi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Natural and Human Sciences (CCNH)</orgName>
								<orgName type="institution">Federal University of ABC (UFABC)</orgName>
								<address>
									<addrLine>Santo André</addrLine>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carina</forename><surname>Colturato-Kido¹</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Milena</forename><forename type="middle">T</forename><surname>Pelegrino</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Natural and Human Sciences (CCNH)</orgName>
								<orgName type="institution">Federal University of ABC (UFABC)</orgName>
								<address>
									<addrLine>Santo André</addrLine>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Edgar</forename><forename type="middle">J</forename><surname>Paredes-Gamero</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Interdisciplinary Center for Biochemistry Investigation (CIIB)</orgName>
								<orgName type="institution">University of Mogi das Cruzes (UMC)</orgName>
								<address>
									<settlement>Mogi das Cruzes</settlement>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Richard</forename><forename type="middle">B</forename><surname>Weller</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Medical Research Council Centre for Inflammation Research</orgName>
								<orgName type="institution" key="instit1">University of Edinburgh</orgName>
								<orgName type="institution" key="instit2">Queen&apos;s Medical Research Institute</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Amedea</forename><forename type="middle">B</forename><surname>Seabra</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Natural and Human Sciences (CCNH)</orgName>
								<orgName type="institution">Federal University of ABC (UFABC)</orgName>
								<address>
									<addrLine>Santo André</addrLine>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="laboratory">Nanomedicine Research Unit (NANOMED)</orgName>
								<orgName type="institution">Federal University of ABC (UFABC)</orgName>
								<address>
									<addrLine>Santo André</addrLine>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Tiago</forename><surname>Rodrigues</surname></persName>
							<email>tiago.rodrigues@ufabc.edu.br</email>
							<affiliation key="aff0">
								<orgName type="department">Center for Natural and Human Sciences (CCNH)</orgName>
								<orgName type="institution">Federal University of ABC (UFABC)</orgName>
								<address>
									<addrLine>Santo André</addrLine>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="laboratory">Nanomedicine Research Unit (NANOMED)</orgName>
								<orgName type="institution">Federal University of ABC (UFABC)</orgName>
								<address>
									<addrLine>Santo André</addrLine>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Prof</roleName><forename type="middle">Tiago</forename><surname>Rodrigues</surname></persName>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Center for Natural and Human Sciences</orgName>
								<orgName type="institution" key="instit1">Federal University of ABC</orgName>
								<orgName type="institution" key="instit2">UFABC. Avenida dos Estados</orgName>
								<address>
									<addrLine>5001. Bloco A, Torre 3, Santo André</addrLine>
									<postCode>623, 090210-580</postCode>
									<settlement>Sala, Santo André</settlement>
									<region>SP, SP</region>
									<country>Brasil. CEP, Brasil</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Edinburgh Research Explorer Antitumor potential of S-nitrosothiol-containing polymeric nanoparticles against melanoma</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">B4BFE4141139A16ED625A4DF18C31D30</idno>
					<idno type="DOI">10.1021/acs.molpharmaceut.7b01001</idno>
					<note type="submission">Link to publication record in Edinburgh Research Explorer Author&apos;s peer reviewed manuscript as accepted for publication.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:30+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Peer reviewed version Cytotoxicity</term>
					<term>Melanoma</term>
					<term>Nanoparticles</term>
					<term>Nitric Oxide</term>
					<term>S-nitrosothiol Cytotoxicity</term>
					<term>Melanoma</term>
					<term>Nanoparticles</term>
					<term>Nitric Oxide</term>
					<term>S-nitrosothiol</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Melanoma is a malignant proliferative disease originated from melanocyte transformations, which are characterized by a high metastatic rate and mortality.</s><s>Advances in Nanotechnology have provided useful new approaches and tools for antitumor chemotherapy.</s><s>The aim of this study was to investigate the molecular mechanisms underlying chitosan nanoparticles containing S-nitroso-mercaptosuccinic acid (S-nitroso-MSA-CS)-induced cytotoxicity in melanoma cells.</s><s>S-nitroso-MSA-CS induced concentration-dependent cell death against B16-F10 tumor cells, whereas non-nitroso nanoparticles (CS or MSA-CS) did not induce significant cytotoxicity.</s><s>Additionally, melanoma cells were more sensitive to cell death than normal melanocytes.</s><s>S-nitroso-MSA-CS-induced cytotoxicity exhibited features of caspasedependent apoptosis and it was associated with oxidative stress, characterized by increased mitochondrial superoxide production and oxidation of protein thiol groups.</s><s>In addition, tyrosine nitration and cysteine S-nitrosylation of amino acid residues in cellular proteins were observed.</s><s>The potential use of these nanoparticles in antitumor chemotherapy of melanoma is discussed.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Skin cancer is the most common type of cancer in Caucasian populations, <ref type="bibr" target="#b0">[1]</ref> and the clinical classifications are based on the tumor origin and divided into non-melanoma skin cancer and melanoma. <ref type="bibr" target="#b1">[2]</ref></s><s>Melanoma arises from cumulative abnormalities in melanocytes in response to ultraviolet-induced DNA damage, resulting in genetic mutations that support their malignancy through stimulation of blood vessel growth, evasion of the immune response and apoptosis, tumor invasion and metastasis. <ref type="bibr" target="#b2">[3]</ref></s><s>Specific gene mutations are associated with an increased risk of melanoma, e.g., the substitution of valine (V) to glutamic acid (E) at position 600 in the BRAF gene (BRAF V600E), which is reported in 40-50% of melanoma cases. <ref type="bibr" target="#b3">[4]</ref></s><s>rly diagnosis of melanoma is crucial for the effectiveness of treatment and favorable prognosis of patients.</s><s>Available tools for melanoma treatment include surgical excision, immunotherapy, radiotherapy, and chemotherapy. <ref type="bibr" target="#b4">[5]</ref></s><s>Immunotherapy (ipilimumab) or targeted therapy (vemurafenib) are the main chemotherapeutic approaches used for the treatment of metastatic melanoma when the BRAF V600E mutation is expressed. <ref type="bibr" target="#b5">[6]</ref></s><s>Antitumor drugs have serious side effects, including hypotension, neutropenia, gastrointestinal and skin dysfunctions, and hair loss. <ref type="bibr" target="#b5">[6]</ref></s><s>Specifically, for the treatment of melanoma, toxic side effects described for vemurafenib include photosensitivity, follicular hyperkeratosis, maculopapular rash, arthralgia, QT prolongation, and others. <ref type="bibr" target="#b6">[7]</ref></s><s>For ipilimumab, the most common side effects described include diarrhea, nausea, constipation, abdominal pain, vomiting, vitiligo and dermatitis, <ref type="bibr" target="#b7">[8]</ref> although more deleterious side effects had already been described such as hepatitis, <ref type="bibr" target="#b8">[9]</ref> enterocolitis, <ref type="bibr" target="#b9">[10]</ref> pancreatitis and nephritis. <ref type="bibr" target="#b10">[11]</ref></s><s>New approaches are emerging in the drug discovery field due to the recent advances in Nanotechnology, providing additional opportunities to overcome drug resistance and toxicity, which are considered the major limitations in melanoma chemotherapy. <ref type="bibr" target="#b11">[12]</ref></s><s>These nanotechnological strategies involve the development of several types of nanostructured drug delivery systems focused on the 5 improvement of the specificity and efficacy of chemotherapeutic drugs, increasing the drug concentration inside the tumor mass, and decreasing toxicity of chemotherapy. <ref type="bibr" target="#b12">[13]</ref></s><s>lymeric nanoparticles form colloidal systems, which are potentially useful for carrying drugs with low water solubility and/or controlling drug release, providing increased stability and drug delivery profile. <ref type="bibr" target="#b13">[14]</ref></s><s>Therefore, chitosan, which is a biocompatible, nontoxic, and biodegradable polymer with pharmaceutical applications, has been widely used for nanoparticle preparation. <ref type="bibr" target="#b14">[15]</ref></s><s>It is well known that nitric oxide ( NO) is involved in various physiological cellular processes such as differentiation and apoptosis. <ref type="bibr" target="#b15">[16]</ref></s><s>At high concentrations, NO exhibit anticancer properties; <ref type="bibr" target="#b16">[17]</ref> however, due to its short half-life in biological environments (1-5 s), it becomes difficult to reach these antitumor concentrations.</s><s>[18] To increase their bioavailability and in vivo stability, low molecular weight molecules capable of acting as NO donors, such as S-nitrosothiols (RSNOs), have been developed. <ref type="bibr" target="#b18">[19]</ref></s><s>Considering that NO-releasing polymeric nanomaterials are emerging as a promising strategy in cancer chemotherapy, <ref type="bibr" target="#b19">[20]</ref> biocompatible chitosan nanoparticles (CS) were synthesized and used to encapsulate low molecular weight mercaptosuccinic acid (MSA), a thiol-containing small molecule.</s><s>Free thiol groups on mercaptosuccinic chitosan nanoparticles (MSA-CS) were nitrosated to form S-nitroso-MSA-containing chitosan nanoparticles (S-nitroso-MSA-CS).</s><s>S-nitroso-MSA belongs to the class of RSNOs and acts as a NO donor.</s><s>S-nitroso-MSA-CS was previously synthesized and characterized and had its cytotoxicity screened in different cancer cells lines. <ref type="bibr" target="#b20">[21]</ref></s><s>Additionally, the transdermal NO delivery in human skin upon dermatological application of S-nitroso-MSA-CS was demonstrated. <ref type="bibr" target="#b21">[22]</ref></s><s>Here, we investigated the underlying mechanisms of cytotoxicity of Snitroso-MSA-CS in an in vitro melanoma model.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>6</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EXPERIMENTAL SECTION</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of MSA-CS and nitrosation to produce S-nitroso-MSA-CS</head><p><s>CS nanoparticles were prepared using an ionotropic gelation process. <ref type="bibr" target="#b22">[23]</ref></s><s>Briefly, 0.1 g of CS was solubilized in 0.1 L of 1% acetic acid plus 66.7 mM MSA.</s><s>Under magnetic stirring, 5.0 mL of 0.6 mg/mL sodium tripolyphosphate was added dropwise in 15 mL of MSA-CS suspension.</s><s>The final mixture was stirred for 45 minutes at 25°C to form the aqueous suspension of CS (1.0 mg/L of CS) containing 7.5 mg/mL of MSA (which corresponds to 50 mM MSA).</s><s>Control CS was prepared without the addition of MSA.</s><s>The thiol groups of MSA-CS were nitrosated by reacting with an equimolar amount of sodium nitrite in acidified medium, as previous described. <ref type="bibr" target="#b23">[24]</ref></s><s>This solution was homogenized, protected from light, incubated for 30 min, and used immediately in experiments.</s><s>The formation of S-nitroso-MSA-CS was confirmed by the detection of S-NO characteristic absorption bands at 336 and 545 nm.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture and standard incubation conditions with NPs</head><p><s>Cell line B16-F10 was purchased from the Rio de Janeiro Cell Bank (BCRJ 0046) (murine melanoma), and Melan-A (murine normal melanocytes) was generously provided by Prof.</s></p><p><s>Miriam Galvonas Jasiulionis (UNIFESP) in 2015.</s><s>Consequently, the authors performed no additional authentication.</s><s>All cell lines were tested to be mycoplasma-free by indirect staining with Hoechst 33258 (Thermo Fisher Scientific, USA) and were used within 3 months of thawing the frozen stock.</s><s>Cells were grown in DMEM (Dulbecco's Modified Eagle's medium) high glucose medium (Sigma-Aldrich, USA) pH 7.2, supplemented with 10% fetal bovine serum (Gibco, Invitrogen, USA), 100 U/mL penicillin and 100 µg/mL streptomycin, in a 5% CO 2 atmosphere at 37°C (Panasonic MCO-19AIC, Japan).</s><s>For experiments, cells were detached, centrifuged (160×g for 10 minutes), and suspended in supplemented DMEM medium.</s><s>B16-F10 cells (5.26×10 4 cells/cm 2 ) were added to microplates for 24 h for cell adhesion.</s><s>After, S-nitroso-MSA-CS (20 and 40 µg/mL) was added and incubated for additional 24 h.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cytotoxicity assays</head><p><s>The cytotoxicity of NPs was screened by the trypan blue dye exclusion assay in B16-F10 melanoma cells and melanocytes Melan-A.</s><s>Compounds were added at increasing concentrations (5.0, 10, 20, and 40 µg/mL) and incubated for 24 h.</s><s>After this, trypan blue was added 0.016% (w/v) and cells were counted using a Neubauer chamber.</s><s>Additionally, the effects of modulators of cell death induced by S-nitroso-MSA-CS were evaluated by the MTT reduction test.</s><s>Thus, after an incubation period, 0.25 mg/mL MTT was added and incubated for 4 h.</s><s>Then, 0.1 mL of 10% SDS was added, incubated overnight, and plates were read at 570 nm/620 nm (Biochrom Asys Expert Plus Microplate Reader, Biochrom Ltd., UK).</s><s>The modulators [50 µM Boc-D-FMK (Sigma-Aldrich, USA), 5 µM MY5445 (Tocris Bioscience, USA), 100 µM PTIO (Sigma-Aldrich, USA)] were pre-incubated 1 hour before the addition of the nanoparticles.</s><s>Cell viability in both assays was calculated in relation to the control (absence of NPs), which was considered as 100%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Lactate dehydrogenase (LDH) release</head><p><s>After a standard incubation, cells were detached and centrifuged (160×g for 10 minutes) and supernatants were kept at 4°C.</s><s>LDH activity released by cells was determined through NADH oxidation measured using the LDH assay kit according to the manufacturer instructions (Labtest Diagnostica SA, Brazil).</s><s>Triton X-100 (0.2%) was used as positive control.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Annexin V-FITC/PI double staining flow cytometry analysis</head><p><s>After a standard incubation, cells were detached, centrifuged (160×g for 10 minutes) and suspended in 50 µL of binding buffer <ref type="bibr" target="#b24">[25]</ref> plus 5.0 µL Annexin V-FITC (BD Biosciences, USA) and 5.0 µL PI (BD Biosciences, USA).</s><s>The mixture was incubated in the dark at room temperature for 20 minutes.</s><s>After addition of 0.3 mL of binding buffer, fluorescence emission was measured with a FACSCanto II Flow Cytometer (BD Biosciences), acquiring 10,000 events per sample using a Coherent® Sapphire™ 488-20 solid state blue laser with an excitation at 488 nm, dichroic mirror 502 LP, bandpass filter 530/30 for the FITC fluorescence channel and dichroic mirror 556 LP, bandpass filter 585/42 for the PI fluorescence channel.</s><s>Data analysis and graphs was completed using Flow Jo vX.0.7 software (Ashland, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Active caspase 3</head><p><s>Caspase 3 was measured by flow cytometry using a monoclonal antibody against the active form.</s><s>After a standard incubation, cells were fixed with 2% paraformaldehyde in PBS for 30 min and permeabilized with 0.01% saponin in PBS for 15 min at room temperature.</s><s>Cells were then collected and incubated with 10 µL anti-active-caspase-3 monoclonal antibody conjugated with FITC #559565 (BD-Pharmingen, USA).</s><s>After a 40-min incubation at 37 °C, the fluorescence emission was analyzed acquiring 10,000 events per sample using blue laser excitation (488 nm), dichroic mirror 502 LP, bandpass filter 530/30 and the FITC fluorescence channel with a FACSCanto II Flow Cytometer.</s><s>Data analysis and graphs were completed using Flow Jo vX.0.7 software.</s><s>After a standard incubation, cells were detached and centrifuged for 10 min at 700×g.</s><s>The pellet was treated with 0.2 ml of 6% trichloroacetic acid and centrifuged at 6000×g for 15 min to precipitate the proteins.</s><s>This precipitate was suspended with 1 ml of 0.5 M potassium phosphate buffer pH 7.6 by vortexing.</s><s>After the addition of 0.1 mM DTNB, absorbance was determined at 412 nm (UV-Visible Spectrophotometer UV-1800, Shimadzu, Japan).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reduced protein thiol content</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reactive oxygen species (ROS) production</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analyses</head><p><s>Values were obtained from at least three independent experiments run in triplicate.</s><s>Data were expressed as the mean ± SEM, and statistical analyses were performed by a one-way analysis of variance (followed by a Tukey post hoc test) with significance defined as *p&lt;0.05,</s><s>**p&lt;0.01,</s><s>*** p&lt;0.001.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Enhanced and selective cytotoxicity of S-nitroso-MSA-CS in melanoma B16-F10 cells</head><p><s>The effects of S-nitroso-mercaptosuccinic acid containing chitosan nanoparticles (S-nitroso-MSA-CS) (Fig. <ref type="figure">1A</ref>) on B16-F10 and Melan-A cell viability were screened by the trypan blue exclusion assay.</s><s>S-nitroso-MSA-CS exhibited high cytotoxicity against the B16-F10 tumor cell line in a concentration-dependent manner after 24 h of incubation.</s><s>Such cytotoxicity was higher in tumor cells than in normal melanocytes (Fig. <ref type="figure">1B</ref>).</s><s>Additionally, non-nitroso MSA chitosan nanoparticles (MSA-CS), empty chitosan nanoparticles (CS), free S-nitroso-MSA, and MSA (in the same molar ratio used in Fig. <ref type="figure">1B</ref>) were evaluated in B16-F10 cells and no significant cytotoxicity was achieved, showing the dependence of the nanoparticle structure (Fig. <ref type="figure">1c</ref>).</s><s>In flow cytometry, the frontal dispersion of the laser (forward scatter, FSC) gives information about the relative cell size and the lateral dispersion (side scatter, SSC) is related to granularity or complexity of the cell.</s><s>S-nitroso-MSA-CS decreased cell size and increased the granularity of melanoma cells, defining a 'dead' population (Fig. <ref type="figure">1D</ref>), which was dependent on concentration (Fig. <ref type="figure">1E</ref>).</s><s>Additionally, S-nitroso-MSA-CS induced the loss of normal morphology, membrane blebbing, cell shrinkage, emission of plasma membrane projections, and disruption.</s><s>The loss of adhesion with the external matrix and neighboring cells was also observed (Fig. <ref type="figure">1F</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S-nitroso-MSA-CS induced apoptosis in melanoma cells</head><p><s>To obtain a better understanding of S-nitroso-MSA-CS-induced cell death, molecular markers of apoptosis and necrosis were evaluated.</s><s>Annexin V-FITC/PI double staining flow cytometry revealed the predominance of double stained B16-F10 cells (annexin V + /PI + ), indicative of late apoptosis (Fig. <ref type="figure" target="#fig_4">2A</ref>).</s><s>Since the dot plot graph is one representative experiment, the quantification of apoptotic cells (annexin V + ), considering all replicates was presented (Fig. <ref type="figure" target="#fig_4">2B</ref>).</s><s>Additionally, the activation of effector caspase 3 during S-nitroso-MSA-CS-induced cell death was shown (Fig. <ref type="figure" target="#fig_4">2C and 2D</ref>).</s><s>The cell-permeable irreversible general caspase inhibitor Boc-D-FMK also prevented cell death (Fig. <ref type="figure" target="#fig_4">2E</ref>), corroborating the participation of caspases.</s></p><p><s>The pre-incubation of B16-F10 cells with necrostatin-1 (Sigma-Aldrich #N9037) and IM-54 (Sigma-Aldrich #SLM0412), inhibitors of necroptosis and necrosis, respectively, did not prevent the S-nitroso-MSA-CS-induced cytotoxicity (Fig. <ref type="figure" target="#fig_4">2F and 2G</ref>).</s><s>In accordance, loss of plasma membrane integrity induced by S-nitroso-MSA-CS was not observed, as evaluated through the absence of LDH release by the cells (Fig. <ref type="figure" target="#fig_4">2H</ref>).</s><s>Thus, S-nitroso-MSA-CS induced caspase-dependent apoptosis in melanoma cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Increased oxidative stress induced by S-nitroso-MSA-CS</head><p><s>A general view of the cellular reactive oxygen species (ROS) production can be achieved by the assessment of oxidized dichlorofluorescein (DCF) fluorescence emission. <ref type="bibr" target="#b25">[26]</ref></s><s>Thus, B16-F10 melanoma cells were incubated with S-nitroso-MSA-CS for 24 h and loaded with CM-H 2 DCFDA.</s><s>As observed in Fig. <ref type="figure" target="#fig_6">3A</ref>, S-nitroso-MSA-CS at 20 and 40 µg/mL (dashed and black lines, respectively) increased ROS generation in B16-F10 melanoma cells.</s><s>Hydrogen peroxide (H 2 O 2 ) was used as a positive control (dotted line).</s><s>The fluorescence quantification of replicates is presented in Fig. <ref type="figure" target="#fig_6">3B</ref>.</s><s>Considering the relative lack of specificity of this fluorophore to identify a specific free radical type, a kinetic measurement of ROS production elicited by S-nitroso-MSA-CS (dashed lines) with CM-H 2 DCFDA was performed for 120 minutes in the presence of catalase conjugated with polyethylene glycol (PEG-CAT, solid lines) (Fig. <ref type="figure" target="#fig_6">3C</ref>).</s><s>The quantification of DCF fluorescence emission at 120 minutes revealed that part of the DCF oxidation at 20 µg/mL S-nitroso-MSA-CS was attributed to the peroxide production but at 40 µg/mL S-nitroso-MSA-CS PEG-CAT did not suppress the emission of fluorescence (Fig. <ref type="figure" target="#fig_6">3D</ref>), indicating that the radical production profile is different depending on the NPs concentration.</s><s>Since H 2 O 2 can be formed by dismutation of superoxide anions produced by mitochondria, we also evaluated the mitochondrial superoxide generation after a 24 h incubation with NPs using MitoSOX™ Red.</s><s>As expected, S-nitroso-MSA-CS also increased the generation of superoxide anion radicals by mitochondria in a concentration dependent fashion (Fig. <ref type="figure" target="#fig_6">3E and 3F</ref>).</s><s>Antimycin A, an inhibitor of the mitochondrial respiratory complex III <ref type="bibr" target="#b26">[27]</ref> was used as positive control (Fig. <ref type="figure" target="#fig_6">3E</ref>, dotted line).</s><s>This increased radical production induced by S-nitroso-MSA-CS was accompanied by oxidation of the thiol group of proteins (Fig. <ref type="figure" target="#fig_6">3G</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cysteine S-nitrosylation and tyrosine nitration promoted by S-nitroso-MSA-CS</head><p><s>The incubation of B16-F10 melanoma cells with S-nitroso-MSA-CS (20 and 40 µg/mL) resulted in an increased formation of 3-nitrotyrosine (Fig. <ref type="figure" target="#fig_8">4A</ref>) and S-nitrosocysteine (Fig. <ref type="figure" target="#fig_8">4B</ref>) in a concentration dependent manner.</s><s>To evaluate whether these observed effects were due to NO released by S-nitroso-MSA-CS, cells were pretreated with the NO scavenger PTIO (Fig. <ref type="figure" target="#fig_8">4C</ref>) and with an inhibitor of cyclic GMP phosphodiesterase MY5445 (Fig. <ref type="figure" target="#fig_8">4D</ref>).</s><s>Both</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>The cytotoxicity of NO donors was described in different tumor cell lines, including ovarian cancer, <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b28">29]</ref> lung carcinoma, <ref type="bibr" target="#b29">[30]</ref> breast adenocarcinoma, <ref type="bibr" target="#b30">[31]</ref> hepatocellular carcinoma <ref type="bibr" target="#b31">[32]</ref> neuroblastoma <ref type="bibr" target="#b32">[33]</ref> and squamous cell carcinoma of the head and neck. <ref type="bibr" target="#b33">[34]</ref></s><s>Such effects were associated with the inhibition of cell proliferation and induction of apoptosis. <ref type="bibr" target="#b34">[35]</ref></s><s>In B16-F10 melanoma cells, organic nitrate NO donors inhibited their metastatic potential, and DETA/NO NO donors reversed the resistance to chemotherapeutic agents, including doxorubicin. <ref type="bibr" target="#b35">[36]</ref></s><s>Additionally, organic nitrate NO donors prevented the formation of melanoma cell lung nodes in a murine melanoma in vivo model. <ref type="bibr" target="#b36">[37]</ref></s><s>These reports suggest the therapeutic potential use of NO donor nanomaterials in many types of cancer antitumor chemotherapy, including melanoma.</s><s>Here, a nanostructured system containing NO and Snitroso-MSA-CS exhibited cytotoxicity against B16-F10 melanoma cells with no significant cytotoxicity in normal melanocytes.</s></p><p><s>The mechanisms of cell death elicited by NO donors depend on several factors, such as cell type and tumor stage.</s><s>Sustained NO production could act as a pro-apoptotic signal by activating caspases <ref type="bibr" target="#b37">[38]</ref> through its effect on mitochondria <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref> or by upregulation of death receptor expression and their sensitization to death ligands, as Fas-L (Fas ligand), TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) and TNF-α (tumor necrosis factorα). <ref type="bibr" target="#b40">[41]</ref></s><s>Our data demonstrated that the cytotoxicity induced by S-nitroso-MSA-CS in melanoma cells is through caspase-dependent apoptosis.</s></p><p><s>It is well established that NO stimulates the soluble guanylyl cyclase resulting in an increase of intracellular cGMP, <ref type="bibr" target="#b41">[42]</ref> whereas cGMP phosphodiesterase leads to a decrease. <ref type="bibr" target="#b42">[43]</ref></s><s>e cGMP phosphodiesterase inhibitor, MY-5445, increases the intracellular cGMP levels and thus mimics the NO effect, <ref type="bibr" target="#b43">[44]</ref> but it did not alter the cytotoxicity of S-nitroso-MSA-CS, as well as the NO scavenger PTIO, despite the detection of NO-protein adducts as discussed 21 below.</s><s>These data suggest that these nanoparticles probably do not act as a NO releasing prodrug.</s></p><p><s>Reactions between NO and −SH groups of protein cysteine residues lead to Snitrosylation, which is an important and reversible post-translational modification able to regulate the activity and function of many proteins and cellular processes. <ref type="bibr" target="#b44">[45]</ref></s><s>S-nitroso-MSA-CS increased cysteine S-nitrosylation and tyrosine nitration in melanoma cells.</s><s>Probably the S-nitroso groups of S-nitroso-MSA-CS were transferred directly to free thiol groups of proteins through S-(trans)nitrosylation.</s><s>In agreement, the occurrence of S-(trans)nitrosylation without release of free NO by RSNOs was previously proposed. <ref type="bibr" target="#b45">[46]</ref></s><s> is well known that the oxidation of protein thiol groups in mitochondrial membranes is related to mitochondrial permeabilization and release of pro-apoptotic proteins to the cytosol, triggering cell death. <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b47">48]</ref></s><s>S-nitrosylation induced by S-nitroso-MSA-CS in melanoma cells was accompanied by oxidative stress characterized by H 2 O 2 and mitochondrial superoxide overproduction, and by nitration of cellular proteins.</s><s>In this regard, mitochondrial dysfunctions elicited by NO donors associated with increased superoxide production have been described. <ref type="bibr" target="#b48">[49]</ref></s><s>Additionally, ruthenium nitrosyl complexes inhibited mitochondrial respiration in hepatocarcinoma cells, resulting in ATP depletion, ROS production, and cell death. <ref type="bibr" target="#b49">[50]</ref></s><s>Increased superoxide production in mitochondria may occur due to nitration and inactivation of manganese-dependent superoxide dismutase <ref type="bibr" target="#b50">[51]</ref> and/or inhibition of the respiratory chain. <ref type="bibr" target="#b51">[52]</ref></s><s>These superoxide can react with NO generating peroxynitrite that nitrates -OH groups in tyrosine residues irreversibly, and the adduct 3nitrotyrosine is widely used as a nitrosative stress marker. <ref type="bibr" target="#b52">[53]</ref></s><s> summary, we presented here the cytotoxic effects of S-nitroso-MSA-CS on B16-F10 melanoma cells.</s><s>Such effects were selective to tumor cells when compared to normal melanocytes and dependent on the entire nanoparticle composition; only CS, free MSA or 22 free S-nitroso-MSA did not exhibit significant cytotoxicity.</s><s>Additionally, the investigation of molecular mechanisms of cytotoxicity revealed that S-nitroso-MSA-CS induced an apoptotic cell death profile, dependent on caspase activation, and associated with a cellular and mitochondrial oxidative stress.</s><s>Together these results point to the potential use of S-nitroso-MSA-CS as an antitumor chemotherapy of melanoma.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST</head><p><s>The other authors disclosed no potential conflicts of interest.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>−SH groups were quantified using 5,5′-dithiobis (2-nitrobenzoic) acid (DTNB).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>After a standard incubation, cells were collected and loaded with 5 µM MitoSOX™ Red or 5 µM CM-H 2 DCFDA (Life Technologies, Invitrogen, USA) for 30 minutes.</s><s>As positive controls, 20 µM antimycin A and 100 µM hydrogen peroxide (H 2 O 2 ) were used.</s><s>End time fluorescence emission was measured using the blue laser with an excitation at 488 nm, dichroic mirror 502 LP, bandpass filter, 530/30 FITC fluorescence channel for CM-H 2 DCFDA and the dichroic mirror 556 LP, bandpass filter 585/42 for the PI fluorescence channel for MitoSOX™ Red with a FACSCanto II Flow Cytometer.</s><s>Data analysis and graphs was completed using Flow Jo vX.0.7 software.</s><s>Alternatively, continuous ROS production was evaluated.</s><s>After incubation with S-nitroso-MSA-CS for 2 h, cells were loaded with 5 µM CM-H 2 DCFDA for 30 min and fluorescence was kinetically recorded for 120 minutes in a microplate reader Synergy HT (Biotek Instruments, USA) at 485 nm and 528 nm excitation and emission, respectively.</s><s>As positive control, 2 mM t-BOOH (Sigma-Aldrich, USA) was used, and 100 U/mL PEGylated catalase (Sigma-Aldrich, USA) was used to distinguish the fluorescence signal attributed exclusively to the peroxide production.Detection of cysteine S-nitrosylation and tyrosine 3-nitration10After a standard incubation, cells were fixed with 2% paraformaldehyde in PBS for 30 min and permeabilized with 0.01% saponin in PBS for 15 min at room temperature.</s><s>Cells were then incubated overnight with the rabbit polyclonal anti-nitrotyrosine primary antibody (#9691, Cell Signaling, USA) (1:200) and mouse monoclonal S-nitrosocysteine primary antibody (#ab94930, Abcam, UK) (1:200).</s><s>After, secondary antibodies − goat anti-Rabbit IgG (H+L) with Alexa Fluor 488 (#A11034, Cell Signaling, USA) (1:500) or goat Anti-Mouse IgG with FITC (#F8521, Sigma-Aldrich, USA) (1:500) − were incubated for one hour at room temperature.</s><s>Nuclei were stained with 5 nM SlowFade® Gold Antifade Mountant with DAPI (Thermo Fisher Scientific, USA) for 15 min.</s><s>Fluorescence emissions were acquired with a widefield fluorescence microscopy system Leica AF6000 (Leica Microsystems, Germany) using the set of cube filters A4 (Ex: 360/40, dichroic mirror: 400 nm: Filter BP: 470/40) and L5 (Ex: 480/40; dichroic mirror: 505 nm; BP filter: 527/30), objective lens HCX APO U-V-I 100 x/1.3 OIL, and camera DFC365FX.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>12 Fig. 1 .</head><label>121</label><figDesc><div><p><s>Fig. 1.</s><s>Enhanced and selective cytotoxicity of S-nitroso-MSA-CS in melanoma B16-F10</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. S-nitroso-MSA-CS induced apoptosis in B16-F10 melanoma cells.</s><s>(A) Cell death</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Oxidative stress in B16-F10 melanoma cells exposed to S-nitroso-MSA-CS.</s><s>(A)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc><div><p><s>able to change the cytotoxicity exerted by S-nitroso-MSA-CS, which provided strong evidence that the protein modifications were not promoted by free cytosolic NO released from the nanoparticles.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. S-nitrosylation and tyrosine nitration of cellular proteins promoted by S-nitroso-</s></p></div></figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>Melan-A cells were kindly provided by Prof. Miriam Galvonas Jasiulionis from the Federal University of São Paulo (Unifesp).</s><s>This work was supported by Brazilian funding agencies FAPESP (2012/12247-8; 2016/07367-5) and CNPq (486760/2013-0).</s><s>CAPES provided the scholarship to Leticia Silva Ferraz.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians</title>
		<author>
			<persName><forename type="first">K</forename><surname>Byrd-Miles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Toombs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Peck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Drugs Dermatol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="10" to="16" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Topical therapies for skin cancer and actinic keratosis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Haque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Thurston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hadgraft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Lane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharm Sci</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="279" to="289" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Actinic keratoses: a comprehensive update</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Dermatol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="43" to="48" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Cutaneous melanoma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Scolyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Kefford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="687" to="701" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Molecular mechanisms for discrete nitric oxide levels in cancer</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Ridnour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Switzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nitric Oxide</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="73" to="76" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Improved survival with vemurafenib in melanoma with BRAF V600E mutation</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hauschild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Robert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Haanesn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ascierto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Larkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dummer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Garbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Testori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page" from="2507" to="2516" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Managing Side Effects of Vemurafenib Therapy for Advanced Melanoma</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Trinh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Adv Pract Oncol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="400" to="410" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mansh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Yale J Biol Med</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="381" to="389" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Molecular mechanisms for discrete nitric oxide levels in cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Chmiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Suan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liddle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nankivell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bautista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fulcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kefford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="237" to="240" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Minor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kashani-Saber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Biother Radiopharm</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="321" to="325" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Ipilimumab: controversies in its development, utility and autoimmune adverse events</title>
		<author>
			<persName><forename type="first">J</forename><surname>Weber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Immunol Immunother</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="823" to="830" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Nanotechnologybased strategies for combating toxicity and resistance in melanoma therapy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Brys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gowda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Loriaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Mosca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biotechnol Adv</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="565" to="577" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Recent advances in targeted nanoparticles drug delivery to melanoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nanomedicine</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="769" to="794" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Biodegradable polymeric Nanoparticles based drug delivery systems</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kumari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Sudesh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Subhash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Colloids Surf B Biointerfaces</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Chitosan Nanoparticles: A positive modulator of innate immune responses in plants</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chandra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chakraborty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dasgupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sarkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Panda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Acharya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">15195</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Nanocarriers for Nitric Oxide Delivery</title>
		<author>
			<persName><forename type="first">J</forename><surname>Saraiva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Marotta-Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Cicillini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Eloy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Marchetti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J drug deliv</title>
		<imprint>
			<biblScope unit="page">936438</biblScope>
			<date type="published" when="2011">2011. 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Nitric oxide donor hybrid compounds as promising anticancer agents</title>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">G</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Discov Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="276" to="284" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Delivering nitric oxide with nanoparticles</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Control Release</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="page" from="190" to="205" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Seabra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Z</forename><surname>Justo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Haddad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biotechnol Adv</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="1370" to="1379" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Nitric oxide releasing nanomaterials for cancer treatment: Current status and perspectives</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Seabra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Lima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Calderón</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Med Chem</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="298" to="308" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Nitric oxide-releasing nanoparticles: synthesis, characterization, and cytotoxicity to tumorigenic cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Pelegrino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Watashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Haddad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Seabra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nanopart Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">57</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Chitosan nanoparticles for nitric oxide delivery in human skin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Pelegrino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Weller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Bernardes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Seabra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">MedChemComm</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="713" to="719" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Synthesis, characterization of chitosan-tripolyphosphate conjugated chloroquine nanoparticle and its in vivo anti-malarial efficacy against rodent parasite: A dose and duration dependent approach</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tripathy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Das</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Chakraborty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Sahu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pramanik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Roy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Pharm</title>
		<imprint>
			<biblScope unit="volume">434</biblScope>
			<biblScope unit="page" from="292" to="305" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus from bovine mastitis</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">F</forename><surname>Cardozo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lancheros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Narciso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Valereto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Seabra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nakazato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Pharm</title>
		<imprint>
			<biblScope unit="volume">473</biblScope>
			<biblScope unit="page" from="20" to="29" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Organopalladium compound 7b targets mitochondrial thiols and induces caspase-dependent apoptosis in human myeloid leukemia cells</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W R</forename><surname>Moraes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C F</forename><surname>Caires</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Paredes-Gamero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rodrigues</surname></persName>
		</author>
		<idno>e658.09</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Physiological roles of the permeability transition pore</title>
		<author>
			<persName><forename type="first">C</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moulin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="1237" to="1247" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Nitric Oxide-Releasing Silica Nanoparticle Inhibition of Ovarian Cancer Cell Growth</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Der</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Schoenfisch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Pharm</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="775" to="785" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kielbik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Szcul-Kielbik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sulowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Klink</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol In Vitro</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="26" to="37" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Synthesis and chemical and biological comparison of nitroxyl-and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives</title>
		<author>
			<persName><forename type="first">D</forename><surname>Basudhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bharadwaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Heinecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Ridnour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Caceres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Spadari-Bratfisch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Chem</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="7804" to="7820" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer</title>
		<author>
			<persName><forename type="first">D</forename><surname>Basudhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bharadwaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Ridnour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Wink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Miranda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Free Radic Biol Med</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="101" to="114" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Effects of nitric oxide on the biological behavior of HepG2 human hepatocellular carcinoma cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Exp Ther Med</title>
				<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1875" to="1880" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Duong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">M</forename><surname>Kamarudin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Erlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kavallaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Commun</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="4190" to="4192" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Forrest</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomaterials</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="3243" to="3253" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The dual role of iNOS in cancer</title>
		<author>
			<persName><forename type="first">F</forename><surname>Vannini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kashfi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Redox Biol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="334" to="343" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Nitric oxidemediated regulation of hypoxia-induced B16F10 melanoma metastasis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Postovit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Lash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Heaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Graham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="47" to="53" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Nitric oxidemediated regulation of chemosensitivity in cancer cells</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Maxwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Gofton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Graham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1879" to="1885" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Billiar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="10954" to="10961" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">p53 expression in nitric oxideinduced apoptosis</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">K</forename><surname>Messmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ankarcrona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nicotera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Brune</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">335</biblScope>
			<biblScope unit="page" from="23" to="26" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Nitric oxide: NO apoptosis or turning it ON?</title>
		<author>
			<persName><forename type="first">B</forename><surname>Brune</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Differ</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="864" to="869" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bonavida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Garban</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Redox Biol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="486" to="494" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Corbin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Rev</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="525" to="563" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Effect of 1-(3-Chloroanilino)-4-Phenylphthalazine (MY-5445), a Specific Inhibitor of Cyclic GMP Phosphodiesterase, on Human Platelet Aggregation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hagiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kanayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hidaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharmacol Exp Ther</title>
		<imprint>
			<biblScope unit="volume">228</biblScope>
			<biblScope unit="page" from="467" to="471" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Therapeutic potential of nitric oxide in cancer</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bonavida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khineche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huerta-Yepes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Garbán</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Resist Upda</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="157" to="173" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Recent developments in nitric oxide donor drugs</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Megson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="305" to="321" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Sensitive and rapid quantization of oxygen reactive species formation in rat synaptosomes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Lebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Bondy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurochem Int</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="435" to="440" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Palladacycles catalyse the oxidation of critical thiols of the mitochondrial membrane proteins and lead to mitochondrial permeabilization and cytochrome c release associated with apoptosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>De Faria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Paredes-Gamero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Caires</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Nantes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rodrigues</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">417</biblScope>
			<biblScope unit="page" from="247" to="256" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">On the mechanisms of phenothiazine-induced mitochondrial permeability transition: Thiol oxidation, strict Ca 2+ dependence, and cyt c release</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>De Faria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">R</forename><surname>Nascimento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rodrigues</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1284" to="1295" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Nitric Oxide and Cell Signaling Pathways in Mitochondrial-Dependent Apoptosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Boyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cadenas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">383</biblScope>
			<biblScope unit="page" from="411" to="423" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Effects on mitochondria of mitochondria-induced nitric oxide release from a ruthenium nitrosyl complex</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Pestana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P S</forename><surname>Phelippin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C M</forename><surname>Polizello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Dorta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Uyemura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Santos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nitric Oxide</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="24" to="30" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Macmillan-Crow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Crow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Kerby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Thompson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="11853" to="11858" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Release of NO from a nitrosyl ruthenium complex through oxidation of mitochondrial NADH and effects on mitochondria</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Pestana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Polizello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Pardo-Andreu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Uyemura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Alberici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Curti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nitric Oxide</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="174" to="181" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry</title>
		<author>
			<persName><forename type="first">J</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Capaldi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="37223" to="37230" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Guanylate cyclase and the NO/cGMP signaling pathway</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Denninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Marletta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1411</biblScope>
			<biblScope unit="page" from="334" to="350" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
